Innate Pharma S.A.

NASDAQ:IPHA

Biotechnology

Healthcare
$1.03 +1.91%

+$0.03 today

Market cap
$115.05M
Beta
0.89
P/E (TTM)
-3.0
EPS (TTM)
-$0.54
52W Low $1.17High $2.63

Volume 0.50M

Average 0.07M

Price history

Innate Pharma S.A. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-42.46%

Period high

$2.54

Period low

$1.03

Latest

$1.03

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
6-KNov 12, 2026Nov 12, 2026
6-KNov 5, 2026Nov 5, 2026
6-KOct 27, 2026Oct 27, 2026
6-KOct 21, 2026Oct 21, 2026
6-KOct 20, 2026Oct 20, 2026
6-KSep 17, 2026Sep 17, 2026
6-KSep 17, 2026Sep 17, 2026
6-KSep 17, 2026Sep 17, 2026
6-KSep 10, 2026Sep 10, 2026
6-KSep 2, 2026Sep 2, 2026
6-KAug 19, 2026Aug 19, 2026
6-KAug 14, 2026Aug 14, 2026
6-KAug 10, 2026Aug 10, 2026
6-KJul 23, 2026Jul 23, 2026
6-KJul 21, 2026Jul 21, 2026

Competitors

Who does Innate Pharma S.A. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about IPHA's filings, answered from its disclosures.

What is the latest IPHA filing?

The latest filing shown is 6-K dated Nov 12, 2026.

How many recent filings does IPHA have?

Intrinsic Alpha currently shows 20 recent filings for IPHA.